Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares saw an uptick in trading volume on Monday . 1,461 shares were traded during mid-day trading, an increase of 72% from the previous session’s volume of 850 shares.The stock last traded at $7.19 and had previously closed at $6.83.
Aspen Pharmacare Price Performance
The company has a current ratio of 2.21, a quick ratio of 1.18 and a debt-to-equity ratio of 0.37. The firm’s 50-day moving average price is $5.74 and its 200 day moving average price is $5.98.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Your Bank Account Is No Longer Safe
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
